Search alternatives:
significant based » significant cause (Expand Search), significant barrier (Expand Search), significant burden (Expand Search)
based decrease » caused decreased (Expand Search), marked decrease (Expand Search), based defense (Expand Search)
teer decrease » greater decrease (Expand Search)
Showing 21 - 40 results of 7,920 for search '(( significant based decrease ) OR ( significant ((teer decrease) OR (mean decrease)) ))', query time: 0.56s Refine Results
  1. 21
    Mean TTC under different weights.

    Mean TTC under different weights. by Jianrong Cai (14245136)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  2. 22
    Distribution of patients in the 4 age groups, mean value of IC-volume from both sides and separately for the left and right ICs.

    Distribution of patients in the 4 age groups, mean value of IC-volume from both sides and separately for the left and right ICs. by Pingling Kwok (14896191)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 23
    Summary of post-treatment disease course measures from MDMA-AT publications.

    Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 24
    Study selection criteria.

    Study selection criteria. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 25
    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.

    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 26
    Disease course measures after the PTSD treatments.

    Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 27
    PICOS criteria for the SLR.

    PICOS criteria for the SLR. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 28
    Summary of post-treatment CAPS score changes from MDMA-AT publications.

    Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 29
    Summary of post-treatment disease course measures from off-label medications clinical trials.

    Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 30
    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.

    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 31
    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.

    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 32
    Summary of post-treatment disease course measures from clinical trials with psychotherapies.

    Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 33
    PRISMA flow chart.

    PRISMA flow chart. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 34
    Summary of clinical efficacy of relevant PTSD treatments.

    Summary of clinical efficacy of relevant PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 35
    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.

    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 36
    Mean persistence (±SE) of GO and GO-GA NPs on <i>Callosobruchus maculatus.</i>

    Mean persistence (±SE) of GO and GO-GA NPs on <i>Callosobruchus maculatus.</i> by Huda H. Elbehery (22492996)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 37
    Mycosis rates (mean % ± SE) of aphids exposed to entomopathogenic fungi from four agroecological zones.

    Mycosis rates (mean % ± SE) of aphids exposed to entomopathogenic fungi from four agroecological zones. by Aime Cheoh Enoh (20141758)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  18. 38
    SD and mean TTC under different weights.

    SD and mean TTC under different weights. by Jianrong Cai (14245136)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  19. 39
    Spearman correlations between the age of the sample donor (20–70 years) and estimated proportions of neuronal, glial, and endothelial cells.

    Spearman correlations between the age of the sample donor (20–70 years) and estimated proportions of neuronal, glial, and endothelial cells. by Arttu Autio-Kimura (20454681)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  20. 40
    Bootstrapped spearman correlations from a randomly selected subset of male sample donor originating samples (n = 493).

    Bootstrapped spearman correlations from a randomly selected subset of male sample donor originating samples (n = 493). by Arttu Autio-Kimura (20454681)

    Published 2024
    Subjects:
    Save to List
    Saved in:

Search Tools: